PubRank

Nick C Fox

Author PubWeight™ 334.80‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011 21.80
2 The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods. J Magn Reson Imaging 2008 14.68
3 Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med 2012 14.14
4 Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 2011 9.90
5 Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet 2011 9.23
6 Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurol 2010 8.74
7 Automatic classification of MR scans in Alzheimer's disease. Brain 2008 6.71
8 Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease. N Engl J Med 2014 6.50
9 Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 2013 6.18
10 11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study. Lancet Neurol 2010 5.03
11 The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol 2010 4.59
12 Tracking atrophy progression in familial Alzheimer's disease: a serial MRI study. Lancet Neurol 2006 4.19
13 Mapping the evolution of regional atrophy in Alzheimer's disease: unbiased analysis of fluid-registered serial MRI. Proc Natl Acad Sci U S A 2002 4.07
14 Longitudinal stability of MRI for mapping brain change using tensor-based morphometry. Neuroimage 2006 3.85
15 Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol 2009 3.82
16 Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis. Lancet Neurol 2010 3.47
17 A longitudinal study of brain volume changes in normal aging using serial registered magnetic resonance imaging. Arch Neurol 2003 3.44
18 Computer-assisted imaging to assess brain structure in healthy and diseased brains. Lancet Neurol 2003 3.26
19 Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study. Lancet Neurol 2007 3.22
20 Fast free-form deformation using graphics processing units. Comput Methods Programs Biomed 2009 3.18
21 Automatic differentiation of anatomical patterns in the human brain: validation with studies of degenerative dementias. Neuroimage 2002 3.06
22 Update on the magnetic resonance imaging core of the Alzheimer's disease neuroimaging initiative. Alzheimers Dement 2010 2.88
23 Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis. Lancet Neurol 2012 2.75
24 Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features. Brain 2012 2.65
25 Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease. Alzheimers Res Ther 2011 2.51
26 Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review. J Neurol Neurosurg Psychiatry 2010 2.44
27 Posterior cortical atrophy. Lancet Neurol 2012 2.41
28 3D characterization of brain atrophy in Alzheimer's disease and mild cognitive impairment using tensor-based morphometry. Neuroimage 2008 2.40
29 Automated cross-sectional and longitudinal hippocampal volume measurement in mild cognitive impairment and Alzheimer's disease. Neuroimage 2010 2.32
30 Early-onset versus late-onset Alzheimer's disease: the case of the missing APOE ɛ4 allele. Lancet Neurol 2010 2.18
31 Increased brain atrophy rates in cognitively normal older adults with low cerebrospinal fluid Aβ1-42. Ann Neurol 2010 2.15
32 A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series. Brain 2008 2.13
33 Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration. Brain 2011 2.13
34 Large C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK population. Am J Hum Genet 2013 2.09
35 Assessing the onset of structural change in familial Alzheimer's disease. Ann Neurol 2003 2.07
36 Magnetic resonance imaging signatures of tissue pathology in frontotemporal dementia. Arch Neurol 2005 2.06
37 Magnetic resonance imaging evidence for presymptomatic change in thalamus and caudate in familial Alzheimer's disease. Brain 2013 2.05
38 Change in rates of cerebral atrophy over time in early-onset Alzheimer's disease: longitudinal MRI study. Lancet 2003 2.02
39 Issues with threshold masking in voxel-based morphometry of atrophied brains. Neuroimage 2008 2.00
40 Head size, age and gender adjustment in MRI studies: a necessary nuisance? Neuroimage 2010 1.99
41 Intensity non-uniformity correction using N3 on 3-T scanners with multichannel phased array coils. Neuroimage 2007 1.93
42 A comparative clinical, pathological, biochemical and genetic study of fused in sarcoma proteinopathies. Brain 2011 1.89
43 STEPS: Similarity and Truth Estimation for Propagated Segmentations and its application to hippocampal segmentation and brain parcelation. Med Image Anal 2013 1.85
44 Amyloid load and cerebral atrophy in Alzheimer's disease: an 11C-PIB positron emission tomography study. Ann Neurol 2006 1.81
45 Shining a light on posterior cortical atrophy. Alzheimers Dement 2012 1.77
46 Imaging markers for Alzheimer disease: which vs how. Neurology 2013 1.76
47 Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy. Mov Disord 2012 1.75
48 The midbrain to pons ratio: a simple and specific MRI sign of progressive supranuclear palsy. Neurology 2013 1.74
49 Robust atrophy rate measurement in Alzheimer's disease using multi-site serial MRI: tissue-specific intensity normalization and parameter selection. Neuroimage 2009 1.71
50 The natural history of Alzheimer disease: a longitudinal presymptomatic and symptomatic study of a familial cohort. Arch Neurol 2004 1.67
51 Accuracy of dementia diagnosis: a direct comparison between radiologists and a computerized method. Brain 2008 1.64
52 Distinct profiles of brain atrophy in frontotemporal lobar degeneration caused by progranulin and tau mutations. Neuroimage 2010 1.62
53 A meta-analysis of hippocampal atrophy rates in Alzheimer's disease. Neurobiol Aging 2008 1.61
54 Volumetric MRI and cognitive measures in Alzheimer disease : comparison of markers of progression. J Neurol 2008 1.60
55 Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer's disease. Alzheimers Dement 2011 1.59
56 Neurofilament inclusion body disease: a new proteinopathy? Brain 2003 1.59
57 Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease. Proc Natl Acad Sci U S A 2013 1.58
58 Ten simple rules for reporting voxel-based morphometry studies. Neuroimage 2008 1.57
59 Whole-brain atrophy rate and cognitive decline: longitudinal MR study of memory clinic patients. Radiology 2008 1.56
60 Comparison of phantom and registration scaling corrections using the ADNI cohort. Neuroimage 2009 1.53
61 Differentiating AD from aging using semiautomated measurement of hippocampal atrophy rates. Neuroimage 2004 1.48
62 Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy. Brain 2006 1.47
63 The clinical profile of right temporal lobe atrophy. Brain 2009 1.46
64 Peregrine and saker falcon genome sequences provide insights into evolution of a predatory lifestyle. Nat Genet 2013 1.45
65 Pathogenic VCP mutations induce mitochondrial uncoupling and reduced ATP levels. Neuron 2013 1.45
66 Volume changes in Alzheimer's disease and mild cognitive impairment: cognitive associations. Eur Radiol 2009 1.43
67 Suspected early dementia. BMJ 2011 1.41
68 VBM signatures of abnormal eating behaviours in frontotemporal lobar degeneration. Neuroimage 2007 1.40
69 The diagnosis of young-onset dementia. Lancet Neurol 2010 1.37
70 Brain imaging in Alzheimer disease. Cold Spring Harb Perspect Med 2012 1.37
71 Brain MAPS: an automated, accurate and robust brain extraction technique using a template library. Neuroimage 2010 1.37
72 Longitudinal and cross-sectional analysis of atrophy in Alzheimer's disease: cross-validation of BSI, SIENA and SIENAX. Neuroimage 2007 1.37
73 Measurements of the amygdala and hippocampus in pathologically confirmed Alzheimer disease and frontotemporal lobar degeneration. Arch Neurol 2006 1.35
74 Long-term follow-up of patients immunized with AN1792: reduced functional decline in antibody responders. Curr Alzheimer Res 2009 1.34
75 Cortical thickness and voxel-based morphometry in posterior cortical atrophy and typical Alzheimer's disease. Neurobiol Aging 2009 1.33
76 Apolipoprotein e genotype modifies the phenotype of Alzheimer disease. Arch Neurol 2006 1.30
77 Molecular nexopathies: a new paradigm of neurodegenerative disease. Trends Neurosci 2013 1.29
78 A comparison of voxel and surface based cortical thickness estimation methods. Neuroimage 2011 1.29
79 Consistent multi-time-point brain atrophy estimation from the boundary shift integral. Neuroimage 2011 1.28
80 Word-finding difficulty: a clinical analysis of the progressive aphasias. Brain 2007 1.27
81 Standardization of analysis sets for reporting results from ADNI MRI data. Alzheimers Dement 2012 1.27
82 Biomarkers for Alzheimer's disease therapeutic trials. Prog Neurobiol 2010 1.26
83 Reduced cortical thickness in the posterior cingulate gyrus is characteristic of both typical and atypical Alzheimer's disease. J Alzheimers Dis 2010 1.23
84 Visual assessment of atrophy on magnetic resonance imaging in the diagnosis of pathologically confirmed young-onset dementias. Arch Neurol 2005 1.22
85 Longitudinal patterns of regional change on volumetric MRI in frontotemporal lobar degeneration. Dement Geriatr Cogn Disord 2004 1.22
86 Differential regional atrophy of the cingulate gyrus in Alzheimer disease: a volumetric MRI study. Cereb Cortex 2006 1.21
87 Parietal lobe deficits in frontotemporal lobar degeneration caused by a mutation in the progranulin gene. Arch Neurol 2008 1.20
88 LoAd: a locally adaptive cortical segmentation algorithm. Neuroimage 2011 1.17
89 Carbon-11-Pittsburgh compound B positron emission tomography imaging of amyloid deposition in presenilin 1 mutation carriers. Brain 2010 1.17
90 Mapping the progression of progranulin-associated frontotemporal lobar degeneration. Nat Clin Pract Neurol 2008 1.17
91 Genetic variability in CLU and its association with Alzheimer's disease. PLoS One 2010 1.16
92 Impaired default network functional connectivity in autosomal dominant Alzheimer disease. Neurology 2013 1.16
93 Defective emotion recognition in early HD is neuropsychologically and anatomically generic. Neuropsychologia 2008 1.15
94 Delusions in frontotemporal lobar degeneration. J Neurol 2009 1.14
95 Whole-brain atrophy as a measure of progression in premanifest and early Huntington's disease. Mov Disord 2009 1.14
96 Accelerating regional atrophy rates in the progression from normal aging to Alzheimer's disease. Eur Radiol 2009 1.14
97 Magnetic resonance imaging measures of brain atrophy in multiple sclerosis. J Magn Reson Imaging 2006 1.14
98 Atrophy rates of the cingulate gyrus and hippocampus in AD and FTLD. Neurobiol Aging 2006 1.12
99 Early-onset Alzheimer disease clinical variants: multivariate analyses of cortical thickness. Neurology 2012 1.10
100 Basic visual function and cortical thickness patterns in posterior cortical atrophy. Cereb Cortex 2011 1.10
101 Atrophy patterns in Alzheimer's disease and semantic dementia: a comparison of FreeSurfer and manual volumetric measurements. Neuroimage 2009 1.09
102 The progression of regional atrophy in premanifest and early Huntington's disease: a longitudinal voxel-based morphometry study. J Neurol Neurosurg Psychiatry 2009 1.09
103 Detecting treatment effects on brain atrophy in relapsing remitting multiple sclerosis: sample size estimates. J Neurol 2007 1.08
104 Cerebral atrophy in mild cognitive impairment and Alzheimer disease: rates and acceleration. Neurology 2013 1.08
105 Accuracy assessment of global and local atrophy measurement techniques with realistic simulated longitudinal Alzheimer's disease images. Neuroimage 2008 1.08
106 An unbiased longitudinal analysis framework for tracking white matter changes using diffusion tensor imaging with application to Alzheimer's disease. Neuroimage 2013 1.07
107 The analysis of repeated 'direct' measures of change illustrated with an application in longitudinal imaging. Stat Med 2004 1.06
108 Increasing power to predict mild cognitive impairment conversion to Alzheimer's disease using hippocampal atrophy rate and statistical shape models. Med Image Comput Comput Assist Interv 2010 1.05
109 Validation of next-generation sequencing technologies in genetic diagnosis of dementia. Neurobiol Aging 2013 1.05
110 An event-based model for disease progression and its application in familial Alzheimer's disease and Huntington's disease. Neuroimage 2012 1.04
111 Does Alzheimer's disease affect hippocampal asymmetry? Evidence from a cross-sectional and longitudinal volumetric MRI study. Dement Geriatr Cogn Disord 2005 1.04
112 Regional brain volumes distinguish PSP, MSA-P, and PD: MRI-based clinico-radiological correlations. Mov Disord 2006 1.04
113 Voxel-based morphometry in tau-positive and tau-negative frontotemporal lobar degenerations. Neurodegener Dis 2004 1.03
114 Patterns of longitudinal brain atrophy in the logopenic variant of primary progressive aphasia. Brain Lang 2013 1.02
115 An automated algorithm for the computation of brain volume change from sequential MRIs using an iterative principal component analysis and its evaluation for the assessment of whole-brain atrophy rates in patients with probable Alzheimer's disease. Neuroimage 2004 1.01
116 Short echo time proton magnetic resonance spectroscopy in Alzheimer's disease: a longitudinal multiple time point study. Brain 2010 1.01
117 Identification of an important potential confound in CSF AD studies: aliquot volume. Clin Chem Lab Med 2013 1.00
118 Gray matter atrophy rate as a marker of disease progression in AD. Neurobiol Aging 2010 0.98
119 Cerebral atrophy measurement in clinically isolated syndromes and relapsing remitting multiple sclerosis: a comparison of registration-based methods. J Neuroimaging 2007 0.97
120 Magnetic resonance imaging predictors of cognition in mild cognitive impairment. Arch Neurol 2007 0.96
121 Automated measurement of hippocampal atrophy using fluid-registered serial MRI in AD and controls. J Comput Assist Tomogr 2007 0.96
122 The importance of group-wise registration in tract based spatial statistics study of neurodegeneration: a simulation study in Alzheimer's disease. PLoS One 2012 0.96
123 White matter tract signatures of the progressive aphasias. Neurobiol Aging 2013 0.95
124 Vascular and Alzheimer's disease markers independently predict brain atrophy rate in Alzheimer's Disease Neuroimaging Initiative controls. Neurobiol Aging 2013 0.95
125 Global gray matter changes in posterior cortical atrophy: a serial imaging study. Alzheimers Dement 2012 0.95
126 Rates of hemispheric and lobar atrophy in the language variants of frontotemporal lobar degeneration. J Alzheimers Dis 2012 0.94
127 MRI derived brain atrophy in PSP and MSA-P. Determining sample size to detect treatment effects. J Neurol 2007 0.94
128 Geodesic information flows. Med Image Comput Comput Assist Interv 2012 0.93
129 Optimizing the design of clinical trials where the outcome is a rate. Can estimating a baseline rate in a run-in period increase efficiency? Stat Med 2008 0.93
130 The pattern of atrophy in familial Alzheimer disease: volumetric MRI results from the DIAN study. Neurology 2013 0.92
131 A volumetric magnetic resonance imaging study of the amygdala in frontotemporal lobar degeneration and Alzheimer's disease. Dement Geriatr Cogn Disord 2005 0.92
132 Using nine degrees-of-freedom registration to correct for changes in voxel size in serial MRI studies. Magn Reson Imaging 2004 0.92
133 Imaging cadavers: cold FLAIR and noninvasive brain thermometry using CSF diffusion. Magn Reson Med 2008 0.91
134 Structural neuroanatomy of tinnitus and hyperacusis in semantic dementia. J Neurol Neurosurg Psychiatry 2011 0.91
135 A novel A781V mutation in the CSF1R gene causes hereditary diffuse leucoencephalopathy with axonal spheroids. J Neurol Sci 2013 0.91
136 The clinical and neuroanatomical phenotype of FUS associated frontotemporal lobar degeneration. J Neurol Neurosurg Psychiatry 2010 0.91
137 Posterior cerebral atrophy in the absence of medial temporal lobe atrophy in pathologically-confirmed Alzheimer's disease. Neurobiol Aging 2011 0.90
138 Automated quantification of caudate atrophy by local registration of serial MRI: evaluation and application in Huntington's disease. Neuroimage 2009 0.90
139 Relationship between CAG repeat length and brain volume in premanifest and early Huntington's disease. J Neurol 2009 0.89
140 Visual ratings of atrophy in MCI: prediction of conversion and relationship with CSF biomarkers. Neurobiol Aging 2012 0.89
141 An algorithmic approach to structural imaging in dementia. J Neurol Neurosurg Psychiatry 2013 0.89
142 The G8 Dementia Research Summit--a starter for eight? Lancet 2013 0.88
143 Profiles of white matter tract pathology in frontotemporal dementia. Hum Brain Mapp 2014 0.87
144 Visualizing the emergence of posterior cortical atrophy. Neurocase 2011 0.87
145 Nothing to say, something to sing: primary progressive dynamic aphasia. Neurocase 2003 0.87
146 MIRIAD--Public release of a multiple time point Alzheimer's MR imaging dataset. Neuroimage 2012 0.87
147 Longitudinal diffusion tensor imaging in frontotemporal dementia. Ann Neurol 2014 0.86
148 Quantitative magnetization transfer imaging in Alzheimer disease. Radiology 2007 0.86
149 Clinical application of measurement of hippocampal atrophy in degenerative dementias. Hippocampus 2009 0.85
150 Atrophy rates in asymptomatic amyloidosis: implications for Alzheimer prevention trials. PLoS One 2013 0.85
151 APOE ε4 is associated with disproportionate progressive hippocampal atrophy in AD. PLoS One 2014 0.85
152 Impact of apolipoprotein E4-cerebrospinal fluid β-amyloid interaction on hippocampal volume loss over 1 year in mild cognitive impairment. Alzheimers Dement 2011 0.85
153 Application of automated medial temporal lobe atrophy scale to Alzheimer disease. Arch Neurol 2007 0.84
154 Memantine and brain atrophy in Alzheimer's disease: a 1-year randomized controlled trial. J Alzheimers Dis 2012 0.84
155 Patterns of cortical thickness according to APOE genotype in Alzheimer's disease. Dement Geriatr Cogn Disord 2009 0.84
156 Presymptomatic generalized brain atrophy in frontotemporal dementia caused by CHMP2B mutation. Dement Geriatr Cogn Disord 2009 0.84
157 Serial volumetric MRI in Parkinsonian disorders. Mov Disord 2009 0.84
158 Phenomenological model of diffuse global and regional atrophy using finite-element methods. IEEE Trans Med Imaging 2006 0.83
159 Accuracy assessment of global and local atrophy measurement techniques with realistic simulated longitudinal data. Med Image Comput Comput Assist Interv 2007 0.83
160 Genetic influences on atrophy patterns in familial Alzheimer's disease: a comparison of APP and PSEN1 mutations. J Alzheimers Dis 2013 0.83
161 New developments in mild cognitive impairment and Alzheimer's disease. Curr Opin Neurol 2006 0.83
162 A framework for using diffusion weighted imaging to improve cortical parcellation. Med Image Comput Comput Assist Interv 2010 0.83
163 Exome sequencing reveals a novel partial deletion in the progranulin gene causing primary progressive aphasia. J Neurol Neurosurg Psychiatry 2013 0.83
164 Brain amyloid-beta fragment signatures in pathological ageing and Alzheimer's disease by hybrid immunoprecipitation mass spectrometry. Neurodegener Dis 2015 0.80
165 Sporadic and familial dementia with ubiquitin-positive tau-negative inclusions: clinical features of one histopathological abnormality underlying frontotemporal lobar degeneration. Arch Neurol 2005 0.80
166 Improved maximum a posteriori cortical segmentation by iterative relaxation of priors. Med Image Comput Comput Assist Interv 2009 0.80
167 Imaging biomarkers in Alzheimer's disease. Ann N Y Acad Sci 2009 0.80
168 Simulation of acquisition artefacts in MR scans: effects on automatic measures of brain atrophy. Med Image Comput Comput Assist Interv 2006 0.80
169 Rate and acceleration of whole-brain atrophy in premanifest and early Huntington's disease. Mov Disord 2010 0.79
170 Targeted recruitment using cerebrospinal fluid biomarkers: implications for Alzheimer's disease therapeutic trials. J Alzheimers Dis 2013 0.79
171 Simulation of local and global atrophy in Alzheimer's disease studies. Med Image Comput Comput Assist Interv 2006 0.79
172 An event-based disease progression model and its application to familial Alzheimer's disease. Inf Process Med Imaging 2011 0.79
173 Cortical folding analysis on patients with Alzheimer's disease and mild cognitive impairment. Med Image Comput Comput Assist Interv 2012 0.78
174 Alzheimer disease: Visual rating of atrophy aids diagnostic accuracy. Nat Rev Neurol 2009 0.78
175 Reply: Implications of presymptomatic change in thalamus and caudate in Alzheimer's disease. Brain 2013 0.78
176 Pure progressive amnesia and the APPV717G mutation. Alzheimer Dis Assoc Disord 2009 0.78
177 Symptoms of memory loss as predictors of cognitive impairment?: the use and reliability of memory ratings in a clinic population. Alzheimer Dis Assoc Disord 2007 0.77
178 Delineating the sites and progression of in vivo atrophy in multiple system atrophy using fluid-registered MRI. Mov Disord 2003 0.77
179 Simulating neurodegeneration through longitudinal population analysis of structural and diffusion weighted MRI data. Med Image Comput Comput Assist Interv 2014 0.77
180 Multiple Orderings of Events in Disease Progression. Inf Process Med Imaging 2015 0.77
181 Structural magnetic resonance imaging-derived biomarkers for Alzheimer's disease. Biomark Med 2007 0.76
182 Cerebral microbleeds in familial Alzheimer's disease. Brain 2011 0.76
183 Correction: Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer's Disease: Results from the DIAN Study Group. PLoS One 2016 0.75
184 Automated template-based hippocampal segmentations from MRI: the effects of 1.5T or 3T field strength on accuracy. Neuroinformatics 2014 0.75
185 Imaging the onset and progression of Alzheimer's disease: implications for prevention trials. J Alzheimers Dis 2013 0.75
186 Does registration of serial MRI improve diagnosis of dementia? Neuroradiology 2010 0.75
187 A peek behind the curtain: amyloid imaging, referrals, and specialist memory evaluations. Alzheimer Dis Assoc Disord 2013 0.75